ES2563210T3 - Cristales multicomponentes constituidos por éster etílico del ácido ([2-amino-6-(4-fluoro-bencilamino)-piridin-3-il]-carbámico y ácido 2-[2-[(2,6-diclorofenil)-amino]-fenil]-acético - Google Patents

Cristales multicomponentes constituidos por éster etílico del ácido ([2-amino-6-(4-fluoro-bencilamino)-piridin-3-il]-carbámico y ácido 2-[2-[(2,6-diclorofenil)-amino]-fenil]-acético Download PDF

Info

Publication number
ES2563210T3
ES2563210T3 ES11805489.9T ES11805489T ES2563210T3 ES 2563210 T3 ES2563210 T3 ES 2563210T3 ES 11805489 T ES11805489 T ES 11805489T ES 2563210 T3 ES2563210 T3 ES 2563210T3
Authority
ES
Spain
Prior art keywords
amino
dichlorophenyl
pyridin
phenyl
ethyl ester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES11805489.9T
Other languages
English (en)
Inventor
Christoph Martin Hoock
Asal Qadan
Bernd Terhaag
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva GmbH
Original Assignee
Teva GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva GmbH filed Critical Teva GmbH
Application granted granted Critical
Publication of ES2563210T3 publication Critical patent/ES2563210T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)

Abstract

Cristal multicomponentes, caracterizado por que consiste en éster etílico del ácido ([2-amino-6-(4-fluorobencilamino)- piridin-3-il]-carbámico (flupirtina) y ácido 2-[2-[(2,6-diclorofenil)-amino]-fenil]-acético (diclofenaco).

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7

Claims (1)

  1. imagen1
    imagen2
ES11805489.9T 2010-12-20 2011-12-20 Cristales multicomponentes constituidos por éster etílico del ácido ([2-amino-6-(4-fluoro-bencilamino)-piridin-3-il]-carbámico y ácido 2-[2-[(2,6-diclorofenil)-amino]-fenil]-acético Active ES2563210T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102010063612 2010-12-20
DE102010063612A DE102010063612A1 (de) 2010-12-20 2010-12-20 Neue Multikomponentenkristalle aus ([2-Amino-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamidsäureethylester und 2-[2-[(2,6-Dichlorphenyl)-amino]-phenyl]-essigsäure
PCT/EP2011/073441 WO2012084975A1 (de) 2010-12-20 2011-12-20 Neue multikomponentenkristalle aus ([2-amino-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamidsäureethylester und 2-[2-[(2,6-dichlorphenyl)-amino]-phenyl]-essigsäure

Publications (1)

Publication Number Publication Date
ES2563210T3 true ES2563210T3 (es) 2016-03-11

Family

ID=45463576

Family Applications (1)

Application Number Title Priority Date Filing Date
ES11805489.9T Active ES2563210T3 (es) 2010-12-20 2011-12-20 Cristales multicomponentes constituidos por éster etílico del ácido ([2-amino-6-(4-fluoro-bencilamino)-piridin-3-il]-carbámico y ácido 2-[2-[(2,6-diclorofenil)-amino]-fenil]-acético

Country Status (9)

Country Link
US (1) US9149468B2 (es)
EP (2) EP3020705A1 (es)
CN (1) CN103261162B (es)
CA (1) CA2821311A1 (es)
DE (1) DE102010063612A1 (es)
EA (1) EA022016B1 (es)
ES (1) ES2563210T3 (es)
PL (1) PL2655328T3 (es)
WO (1) WO2012084975A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010063609A1 (de) * 2010-12-20 2012-06-21 Awd.Pharma Gmbh & Co. Kg Neue Multikomponentenkristalle aus ([2-Amino-6-(4-fluoro-benzylamino)-pyridin-3yl)-carbamidsäureethylester und einer Arylpropionsäure

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3601195A1 (de) * 1985-01-23 1986-07-24 Degussa Ag, 6000 Frankfurt Synergistische kombination von flupirtin und nicht-steroidalen antiphlogistika
DE3665538D1 (en) * 1985-01-23 1989-10-19 Asta Pharma Ag Synergistic combination of flupirtin and non-steroidal anti-phlogistics
FI855016A7 (fi) 1985-06-28 1986-12-29 Degussa Flupirtiinin ja 4-asetamido-fenolin synergistinen yhdistelmä.
DE19705555A1 (de) 1997-02-13 1998-08-20 Ulrich Dr Posanski Pharmazeutische Präparate der Thioctsäure zur oralen Anwendung
DE19716984A1 (de) 1997-04-23 1998-10-29 Asta Medica Ag Verfahren zur Herstellung von reinem Flupirtin-Maleat und dessen Modifikation A
EP1701725B1 (en) 2003-12-16 2013-07-31 Relevare Aust. Pty Ltd Compositions comprising flupirtine and an opioid for use in the treatment of neuropathic pain
US7553858B2 (en) 2003-12-17 2009-06-30 Meda Pharma Gmbh & Co. Kg Combination of flupirtine and tramadol
US20090285862A1 (en) 2006-05-03 2009-11-19 Cnsbio Pty Ltd. Methods and composition for treatment of inflammatory pain
EP2123626A1 (en) * 2008-05-21 2009-11-25 Laboratorios del Dr. Esteve S.A. Co-crystals of duloxetine and co-crystal formers for the treatment of pain
US8222282B2 (en) * 2008-06-09 2012-07-17 Teva Pharmaceuticals Usa, Inc. Sulfonate salts of 2-amino-3-carbethoxyamino-6-(4-fluoro-benzylamino)-pyridine
US8183267B2 (en) * 2008-06-09 2012-05-22 Awd. Pharma Gmbh & Co. Kg Carboxylic acid salts of 2-amino-3-carbethoxyamino-6-(4-fluoro-benzylamino)-pyridine

Also Published As

Publication number Publication date
EP3020705A1 (de) 2016-05-18
US9149468B2 (en) 2015-10-06
EP2655328B1 (de) 2015-11-18
PL2655328T3 (pl) 2016-07-29
WO2012084975A1 (de) 2012-06-28
EA201300601A1 (ru) 2013-09-30
CN103261162B (zh) 2016-06-15
DE102010063612A1 (de) 2012-06-21
US20130261157A1 (en) 2013-10-03
EA022016B1 (ru) 2015-10-30
CN103261162A (zh) 2013-08-21
EP2655328A1 (de) 2013-10-30
CA2821311A1 (en) 2012-06-28

Similar Documents

Publication Publication Date Title
ES2525918T3 (es) Proceso para la fabricación de Nicorandil
CY1122951T1 (el) Φαρμακευτικα σκευασματα ενος αναστολεα υδροξυλασης ηιf
ES2661582T3 (es) Efecto antiinflamatorio de la celulosa microfibrilada
ES2487271T3 (es) Formulaciones de dosificación sólidas inhibidoras de DPP-IV
CY1120805T1 (el) Κρυσταλλικες μορφες αναστολεα προλυλο υδροξυλασης
BR112014013872A2 (pt) amidas dos ácidos n-(1,2,5-oxadiazol-3-il) -, n-(1,3,4-oxadiazol-2-il)-, n-(tetrazol - 5 - il) - e n - (triazol -5-il) - aril-carboxílico e sua utilização enquanto herbicidas
UA110642C2 (uk) Композиція гербіциду і сафенеру
CU20120147A7 (es) Procedimiento para la preparación de 4-{ 4-[({[4-cloro-3-(trifluorometil)fenil]amino}carbonil)amino]-3-fluorofenixi}-n-metilpiridina-2-carboxamida y su monohidrato
EP2685505A4 (en) THIN FILM TRANSISTOR, MANUFACTURING METHOD AND DISPLAY DEVICE THEREFOR
CY1121895T1 (el) Σκευασματα διαλυματος κατασκευασμενων αντισωματων anti-il-23p19
ES2421956B1 (es) Nueva forma cristalina de sulfato de sitagliptina
ECSP078030A (es) Formas cristalinas y otras formas de las sales de ácido láctico de 4-amino-5-fluoro-3-[6-(4-metilpiperazin -1-il)-1h-bencimidazol-2 -il]-1h-quinolin-2-ona
MX377589B (es) Composiciones sólidas que comprenden agonista de glp-1 y sal del ácido n-(8-(2-hidroxibenzoil)amino)caprílico.
CL2008003088A1 (es) Metodo de preparacion de la sal de de maleato de (e)-n-{4-[3-cloro-4-(2-piridinilmetoxi)anilino]-3-ciano-7-etoxi-6-quinolinil}-4-(dimetilanino)-2-butenamida; formas cristalinas anhidra y monohidrato de la sal maleato; metodo de preparacion; composicion farmaceutica; utiles en el tratamiento de cancer.
EA201200728A1 (ru) Новые сокристаллы агомелатина, способ их получения и фармацевтические композиции, которые их содержат
BR112015005369A2 (pt) inibidores de usp30 e métodos para sua utilização
CL2007003389A1 (es) Formas cristalinas de sales de acido zoledronico; composicion farmaceutica; y uso en el tratamiento del cancer.
CL2013000488A1 (es) Co-cristales de compuestos derivados de (2r)-5-oxo-1-(bencilpiperidin-4-il)-n-(piridin-2-il)pirrolidin-2-carboxamida y un agente de formacion de co-cristales; sales de los compuestos; compuestos intermediarios; composicion farmaceutica; y su uso para el tratamiento de enfermedades inflamatorias e infecciosas.
CL2013003563A1 (es) Compuestos derivados de amidas del ácido gambógico y sus sales; composición farmacéutica que los comprende, útil en el tratamiento del glioblastoma.
AR083268A1 (es) Conjugado de naloxol-peg cristalino
SV2009003286A (es) Sal de potasio cristalina de analogos de lipoxina a4
CR10052A (es) Proceso para la preparación de aminas
ECSP11011286A (es) Formulaciones orales sólidas de una pirido-pirimidinona
ECSP13012608A (es) Nuevas formas cristalinas de la sal sódica del ácido (4-{4-[5-(6-trifluoro-metil-piridin-3-il-amino)-piridin-2-il]-fenil}-ciclohexil)-acético
ES2563210T3 (es) Cristales multicomponentes constituidos por éster etílico del ácido ([2-amino-6-(4-fluoro-bencilamino)-piridin-3-il]-carbámico y ácido 2-[2-[(2,6-diclorofenil)-amino]-fenil]-acético